Pharmspective and Atlantic Information Services Announce Digital Knowledge Management Partnership
Leading healthcare information providers to create digital information apps from news and research content.
Pharmspective Launches Affordable Care Act eLearning for Healthcare Decision-Makers
ACA E-modules provide comprehensive training solution to bridge Obamacare knowledge gap.
Pharmspective introduces PolicyView™
New specialty drug medical policy aggregator will simplify assessments of Pharma market access landscape.
Pharmspective and Mark Farrah Associates Partner to Offer Pharma Intelligence Solutions
Collaboration will build pharma business intelligence apps and syndicated research offerings for the post-ACA market access landscape.
Pharmspective Launches Affordable Care Act Knowledge and ￼News Hub for Healthcare Decision-Makers
Healthcarereforminsider.com will provide actionable news, research, and policy perspectives on the Affordable Care Act for strategic decisions.
State Exchange Benchmark Plan Choices Present New Challenges for Exchange Insurers and Pharmaceutical Companies
New Pharmspective Report Covers Implications of Benchmark Plan Selections on Access and Coverage of Pharmaceuticals.
Pharmspective Releases New Pipeline Perspectives Reports in Key Autoimmune Diseases
Rheumatoid Arthritis Pipeline Perspectives and Psoriasis Pipeline Perspectives are the first in a series of comprehensive assessments of product development in specialty therapeutic areas.
Supreme Court Ruling Creates New Demand for Pharmspective’s ClearView ™ Healthcare Reform App
Company rolls out expanded knowledge management system to support strategic planning and training of pharma clients for transition to new era.
Pharmspective Releases Rheumatoid Arthritis Adoption Insights Report
Rheumatologist survey covers new factors influencing treatment strategies and prescribing of biologics.
Pharmspective, a Specialty Therapeutics Market Research Firm, Announces Launch of Syndicated Research Offering and Knowledge Management Apps for the Pharmaceutical Industry
Providing insights into the buying process for specialty therapeutics in Autoimmune diseases and Oncology